Vr Bjm Hd Wallpapers For Mac
TOP DOWNLOADS BEST SELLERS ABOUT US EleFun Desktops is a world-wide leader in the production of Animated Wallpapers and Animated Screensavers for the PC desktops. Our huge collection includes: free screensavers and animated themes, holiday and season screen savers, 3D Aquarium, Animals, Waterfalls, Nature and many other screen saver and animated wallpaper for free and for order. NEWS RSS FEEDS Live Motion Free wallpapers Animated Desktop wallpapers Version 5.07 price: free size: 5.53MB Systems Requirements: Pentium II, 128 RAM, Windows XP / 2000 / 98 Not compatible with Windows Vista “Live Motion” - Animated Desktop Wallpaper by EleFun Multimedia. Do you enjoy your desktop having beautiful wallpaper? Just have a look at Animated Desktop Wallpaper “Live Motion”. Continuous motion is enchanting. There is something hypnotic in it, which make you stare and stare at it without being diverted to something else.
Constant, live motion. It is not subject to the forces of nature.
It looks like a matrix. But there are no digits here. Live motion is just a motion. It is like the doors to the other world, which you can enter only watching the motion. Install Animated Desktop Wallpaper “Live Motion” and keep watching as long as you wish. Screen Mate Dear users!
As you know, st. Valentine's day is coming soon. On this day of all beloved, we are happy to make you this remarkable present: Valentines Hearts Screen Mate! EleFun Desktops team from the bottom of the heart wishes you a happy New Year!
Let in 2009 all your most treasured dreams will come true! Good luck to you, health and family happiness! EleFun Desktops team wishes you Merry Christmas! Christmas is very close! Do not forget to decorate your desktops with EleFun Desktops' Christmas Screensavers and Animated Wallpapers! SUBSCRIBE Subscribe to our news! Live Motion:: Free Animated Desktop wallpapers from EleFun-Desktops.com eleFun multimedia network (c) 2000-2007.
Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus? Int J Cardiol. 2018 06 15;261:54-57 Authors: Godart F, Houeijeh A, Domanski O, Guillaume MP, Brard M, Lucron H Abstract AIM: To describe our initial experience with the Occlutech Duct Occluder (ODO) for percutaneous closure of patent ductus arteriosus (PDA). METHODS: Retrospective review of patients undergoing transcatheter PDA closure with the ODO in 2 academic centers.
RESULTS: From April 2013 to September 2017, 42 patients underwent PDA closure. Median age at implantation was 34 months (range 4 months-68 years) and median weight was 12 kg (range 4.1-57 kg). Ducts were Krichenko type A duct (n = 34), type E (n = 6), and type C (n = 2). The mean duct diameter was 3.76 mm (range 1.69 to 9.95 mm, median 3.1 mm). Implantation succeeded in all. There was neither device embolization nor hemolysis.
At device release, immediate angiogram showed a small residual shunt in 54.7%. During follow-up, Doppler echocardiography demonstrated 71% of full occlusion at day one, rising to 95% at one month and 100% at one year and half after implantation. The mean maximal systolic pressure gradient in left pulmonary artery was 4.2 ± 4.3 mm and across the distal aortic arch 5.4 ± 4.7 mm Hg.
No patient had any significant stenosis with clinical relevance. CONCLUSIONS: ODO is safe and effective in transcatheter closure of PDA including relatively large sized ducts. The results are satisfactory with a high level of full occlusion and a low rate of complications. Further evaluation with larger studies and longer follow-up will be required to confirm these preliminary good results. PMID: 29551254 PubMed - indexed for MEDLINE. Ventricular efficiency in pregnant women with congenital heart disease.
Vr Bjm Hd Wallpapers For Mac 1920x1080
Int J Cardiol. 2018 06 15;261:58-61 Authors: Muneuchi J, Yamasaki K, Watanabe M, Fukumitsu A, Kawakami T, Nakahara H, Joo K Abstract BACKGROUNDS: Pregnant women with congenital heart disease (CHD) are at risk of cardiovascular events during pregnancy as well as postpartum.
The aim of our study is to address the feasibility of echocardiography-derived ventricular-arterial coupling during pregnancy and postpartum among women with CHD. METHODS: In 31 pregnant women with CHD, we performed serial echocardiography at the first and third trimesters, early and late postpartum. The indices of contractility (single-beat determined end-systolic elastance, Eesab) and afterload (effective arterial elastance, Ea) were approximated on the basis of the systemic blood pressure and systemic ventricular volume. The ratio of stroke work and pressure-volume area (SW/PVA) representing ventricular efficiency was also calculated. RESULTS: Age at the delivery was 28 (24-31) years. ZAHARA score was 0.75 (0.75-1.50).
Gestational age and birth weight of newborns were 38 (37-39) weeks and 2.73 (2.42-2.92) kg, respectively. Heart rate, systemic ventricular end-diastolic volume and stroke volume significantly increased from the first trimester to the third trimester and reversed postpartum to the values of the first trimester. Eesab and Ea significantly decreased from the first trimester to the third trimester (Eesab; 4.90 2.86-7.14 vs 3.41 2.53-4.61 mm Hg/ml, p = 0.0001, Ea; 2.83 1.74-3.30 vs 2.18 1.67-2.68 mm Hg/ml, p = 0.0012), and reversed early postpartum parallelly. Ejection fraction and SW/PVA remained unchanged throughout pregnancy and postpartum. CONCLUSIONS: Echocardiography-derived ventricular-arterial coupling is feasible to understand ventricular function in pregnant women with CHD. PMID: 29657057 PubMed - indexed for MEDLINE.
Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR‑29c in chronic hypoxia. 2018 Sep;18(3):3451-3460 Authors: Zhu Y, Feng Z, Jian Z, Xiao Y Abstract Cardiac fibroblast‑myofibroblast transformation (FMT) contributes to the fibrotic deterioration evoked by chronic hypoxia. Growing evidence implicates long noncoding RNAs (lncRNAs) in various types of cardiac physiological and pathological processes, especially in cardiac fibrosis. In the present study, the lncRNA Taurine Upregulated Gene 1 (TUG1), reported as a regulator of hypoxia fibrosis in the lungs, was found to also be an important regulator of cardiac FMT. Specifically, the possible role of TUG1 in cardiac FMT and fibrosis under chronic hypoxia was investigated. It was revealed that the degree of fibrosis in heart tissues collected from congenital heart surgery patients with low pulse oxygen saturation and mice housed under chronic hypoxic and atmospheric pressure conditions was negatively correlated with pulse oxygen saturation.
Moreover, TUG1 expression was positively correlated with the degree of fibrosis but negatively correlated with pulse oxygen saturation. Cardiac fibroblasts showed increased myofibroblast marker, collagen I and α‑SMA expression levels as the hypoxia time increased. TUG1 knockdown ameliorated the hypoxia‑induced FMT. A bioinformatics analysis predicted that TUG1 had miR‑29c binding sites in its 3'‑UTR and miR‑29c is a key regulator of cardiac fibrosis. The present study demonstrated that TUG1, along with miR‑29c, may contribute to cardiac FMT activation and promote fibrosis in chronic hypoxia.
Sony nwz b143f drivers for mac. You are reporting the following post: SONY NWZ B143F compatible with Mac? This post has been flagged and will be reviewed by our staff. Thank you for helping us maintain CNET's great community. Support by Sony mobile app: stay informed about news, software/firmware updates and more! Downloads Unfortunately, there currently are no downloads for this product.
PMID: 30066872 PubMed - indexed for MEDLINE. Insights on Atrial Fibrillation in Congenital Heart Disease. Can J Cardiol. 2018 Nov;34(11):1531-1533 Authors: Ebrahim MA, Escudero CA, Kantoch MJ, Vondermuhll IF, Atallah J Abstract Patients with congenital heart disease (CHD) have been surviving late into adulthood, with atrial arrhythmias being the most common long-term complication. In recent reports, atrial fibrillation (AF) tended to be the most common form of arrhythmias among groups of patients with adult CHD (ACHD) older than 50 years of age. When compared with their adult counterparts without CHD, AF in patients with ACHD has been characterized by a higher incidence and prevalence, younger age of onset, and a greater risk of progression to persistent AF.
Risk factors for the development of AF are not well known but include older age, left atrial dilation, systemic hypertension, and multiple cardiac surgeries. Data on management options such as optimal antiarrhythmic drug therapy, indications for anticoagulation, and efficacy and safety of catheter ablation are limited. There is a crucial need for further research exploring management, prevention, and monitoring strategies for the growing ACHD patient population with AF. This report will provide a contemporary review of the epidemiology, pathophysiology, and management options for AF in this complex patient population.
PMID: 30404756 PubMed - in process. Additional superior vena cava combined with abnormal inflow of the hepatic vein. Asian Cardiovasc Thorac Ann. 2018 Sep;26(7):566-569 Authors: Bockeria LA, Bockeria OL, Sanakoev MK, Shvartz VA, Le TG Abstract We represent a case of successful surgical treatment of a rare congenital heart disease: abnormal inflow of an additional superior vena cava into the left atrium, combined with atrial septal defect, mitral and tricuspid valve regurgitation, and abnormal inflow of the left hepatic vein into a roofless coronary sinus.
PMID: 27206782 PubMed - indexed for MEDLINE. Fetal and Postnatal Echocardiographic Diagnosis of Ebstein Anomaly of the Mitral Valve.
Pediatr Cardiol. 2018 Aug;39(6):1276-1279 Authors: Aly S, Bokowski J, Diab K, Muller BA Abstract Ebstein anomaly of mitral valve (MV) is an extremely rare congenital heart disease. In the current report, we present a case of Ebstein of MV that was diagnosed prenatally. Fetal echocardiogram showed that the posterior leaflet of MV was tethered to the lateral wall of left ventricle (LV) with downward displacement into LV cavity. Postnatal transthoracic and transesophageal echocardiograms confirmed the diagnosis with apical displacement of the level of coaptation MV into the LV cavity. To the best of our knowledge, fetal diagnosis of Ebstein anomaly of MV has not yet been reported in the medical literature.
PMID: 29756160 PubMed - indexed for MEDLINE. Successful simultaneous transcatheter treatment for a secundum atrial septal defect complicated by valvular pulmonary stenosis in an infant.
Cardiol Young. 2018 Oct;28(10):1162-1164 Authors: Asada D, Tomita H, Fujii T Abstract Only few reports have described successful simultaneous transcatheter intervention for CHD in infants. We present an infant with secundum atrial septal defect complicated by valvular pulmonary stenosis. Percutaneous transcatheter pulmonary valvuloplasty was performed first, followed by transcatheter closure of the secundum atrial septal defect uneventfully.
Simultaneous transcatheter correction is an effective therapeutic option even in infants. PMID: 29991370 PubMed - indexed for MEDLINE. Advanced care planning in adult congenital heart disease: Transitioning from repair to palliation and end-of-life care. Int J Cardiol. 2018 Oct 26;: Authors: Troost E, Roggen L, Goossens E, Moons P, De Meester P, Van De Bruaene A, Budts W Abstract As a result of advances in pediatric care, the majority of patients born with congenital heart disease (CHD) survive into adulthood 1.
Effective transfer and transition programs assure that patients with CHD remain in follow-up and receive continuous holistic care. Unfortunately, adult patients with CHD carry residual lesions and sequelae putting them at risk for premature death related to re-interventions or complications; most commonly heart failure and arrhythmia 2. The scientific adult CHD (ACHD) community has been working hard to identify variables related to worse outcomes, modifying those where possible in order to improve survival. Indeed, survival in adults with CHD has increased, but consequently, on top of CHD-related complications, patients are increasingly exposed to the standard cardiovascular risk factors. Therefore, a program for lifelong coaching on health behavior and life style management becomes indispensable. More emerging is that a substantial number of patients, in particular those with complex heart defects, will eventually end up in a stage with hardly any medical or interventional options left.
Our healthcare provision has to be prepared to organize care for this specific group of patients who will die prematurely and require the timely development and establishment of advanced care planning. Advanced care planning should preferentially be set-up in expert CHD centers. The long-lasting relationship in ACHD care with healthcare providers offers an excellent basis with regards to prognosis, advanced care planning and end-of-life issues.
PMID: 30413300 PubMed - as supplied by publisher. Assessment of a novel radiation reduction protocol for pediatric and adult congenital device implantation. J Interv Card Electrophysiol.
2018 Nov 09;: Authors: Clark BC, Janson CM, Ceresnak SR, Osei FA, Bonney WJ, Nappo L, Pass RH Abstract PURPOSE: Device implantation requires fluoroscopic guidance, which carries inherent risks of ionizing radiation. We evaluated the impact of a low-dose fluoroscopic protocol on radiation exposure during device implantation. METHODS: All patients who underwent pacemaker or ICD implantation with new transvenous leads from July 2011 to January 2018 were included. A novel ALARA protocol consisting of ultra-low frame rates (2-3 frames/s), low dose/frame (6-18 mGy/frame), and use of the 'air-gap' technique in patients. Current understanding and perioperative management of pediatric pulmonary hypertension.
Vr Bjm Hd Wallpapers For Mac Download
Paediatr Anaesth. 2018 Nov 10;: Authors: Latham GJ, Yung D Abstract Pediatric pulmonary hypertension (PH) is a complex disease with multiple, diverse etiologies affecting the premature neonate to the young adult. Pediatric pulmonary arterial hypertension (PAH), whether idiopathic or associated with congenital heart disease, is the most commonly discussed form of pediatric PH, as it is progressive and lethal. However, neonatal forms of PH are vastly more frequent, and while most cases are transient, the risk of morbidity and mortality in this group deserves recognition. PH due to left heart disease is another subset increasingly recognized as an important cause of pediatric PH. One aspect of pediatric PH is very clear: anesthetizing the child with PH is associated with a significantly heightened risk of morbidity and mortality. It is therefore imperative that anesthesiologists who care for children with PH have a firm understanding of the pathophysiology of the various forms of pediatric PH, the impact of anesthesia and sedation in the setting of PH, and anesthesiologists' role as perioperative experts from preoperative planning to postoperative disposition.
This review summarizes the current understanding of pediatric PH physiology, preoperative risk stratification, anesthetic risk, and intraoperative considerations relevant to the underlying pathophysiology of various forms of pediatric PH. This article is protected by copyright. All rights reserved. PMID: 30414333 PubMed - as supplied by publisher Pages.